Northeast Region - From Diagnosis to Decisions: Taking Charge of Your AML Care image

Northeast Region - From Diagnosis to Decisions: Taking Charge of Your AML Care

Sep 15, 2025
12:00PM - 01:00PM EDT
Online Event
Overview

Join us for this free, virtual, regional event designed to help you better understand your AML diagnosis and feel more confident in making treatment decisions. Dr. Catherine Lai from the University of Pennsylvania will walk us through the basics of AML, the importance of genetic testing, and how to advocate for the best care with your healthcare team. You’ll also be introduced to local resources, support organizations, and others in your area who understand what you're going through. Join us to get informed, ask questions, and feel more equipped to take the next steps in your care.

Agenda
12:00 PM
Introduction
Mary Arnett

Mary introduces the agenda for the event and featured speaker Catherine Lai, MD, MPH

12:05 PM
Presentation
Catherine Lai, MD, MPH

Dr. Lai talks about AML basics and testing

12:35 PM
Questions and Answers
Audience

Type your questions in the chat and we will answer them! 

12:50 PM
Local Resource Sharing
Mary Arnett
Speakers & Moderators
Healthtree contact Mary Arnett

Mary Arnett

Mary joined HealthTree in 2022 as a part of HealthTree's team to help expand into all blood cancers. She now works as HealthTree's Volunteer & Community Outreach Manager, helping to engage and involve community members in HealthTree's mission. When she isn't working, she loves being the fun aunt to her 13 nieces and nephews, attending concerts, experimenting with new recipes in the kitchen, and traveling to explore new cities.

Healthtree contact Catherine Lai, MD, MPH

Catherine Lai, MD, MPH

Dr. Lai is an Associate Professor and Physician Leader of the Leukemia Clinical Research Unit at University of Pennsylvania’s Perelman Center for Advanced Medicine. Board-certified in hematology, oncology and internal medicine, she specializes in detecting, monitoring, and treating acute leukemias and myeloid malignancies in adults. Dr. Lai's research focuses on novel therapeutics, designing and conducting clinical trials, and health outcomes for leukemia and myeloid malignancy patients.